This month featured ESMO updates, breast cancer trial news, social media strategies for oncologists, and mastectomy body image issues.

Researchers assessed preoperative lesion area as a predictor of final defect size in periocular basosquamous carcinoma cases.

Perioperative apalutamide plus ADT and surgery lowered risk of recurrence or death by 62% in high-risk localized or locally advanced prostate cancer.

Sanjay Juneja, MD, a triple board-certified hematologist and medical oncologist known as @TheOncDoc, translates oncology ...

Over the last 15 years, low-risk prostate cancer has become less common at diagnosis and is increasingly managed through active surveillance, according to research published in Ca ...

In patients with extensive-stage small cell lung cancer, adding tarlatamab to durvalumab maintenance therapy significantly ...

Women with early-onset cancer who use fertility preservation are likely to be unmarried, privately insured city dwellers with blood or breast cancer.

Pembrolizumab continues to demonstrate a disease-free and overall survival benefit for patients with clear cell renal ...

In patients with muscle-invasive bladder cancer (MIBC), treatment with neoadjuvant durvalumab and enfortumab vedotin, with or ...

Combining adjuvant ribociclib with an NSAI improves long-term survival in HR-positive, HER2-negative early breast cancer over ...

Investigators assessed the relationship between distinct symptom clusters and quality of life in patients who underwent thyroid cancer surgery.

Niraparib plus dostarlimab with definitive cisplatin plus radiotherapy improves some outcomes in patients with locally ...